Laddar...
Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial
Background: We previously reported an open-label prospective trial of subcutaneous immunoglobulin (SCIg) in mild to moderate exacerbations of myasthenia gravis (MG). The effective dose of SCIg in MG and whether measured immunoglobulin G (IgG) levels correlated with measures of disease burden were no...
Sparad:
| I publikationen: | Front Neurol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477386/ https://ncbi.nlm.nih.gov/pubmed/32982936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00921 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|